The burden of gestational diabetes mellitus in Jamaican women with a family history of autosomal dominant type 2 diabetes

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 23, Issue 2, 2008, Pages 85-91

  Irving, Rachael R ^a   Mills, James L ^a   Choo Kang, Eric G ^a   Morrison, Errol Y ^a   Kulkarni, Santosh ^a   Wright Pascoe, Rosemarie ^a   Mclaughlin, Wayne ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

Diabetes gestational; Diabetes mellitus; Genetics, medical; Jamaica

Indexed keywords

DIABETES; GENETICS; PREGNANCY; WOMENS HEALTH;

CHICAGO; ILLINOIS; NORTH AMERICA; UNITED STATES;

EID: 42149100624     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/S1020-49892008000200003     Document Type: Article

References (42)

1. Rosenbloom A, Joe J, Young R, Winter W. Emerging epidemic of type diabetes in youth. Diabetes Care. 1999;22(2):345-54.
2. Doria A, Yang Y, Malecki M. Phenotypic characteristics of early-onset autosomal-dominant type 2 diabetes unlinked to known maturity-onset diabetes on the young (MODY) genes. Diabetes Care. 1999;22:253-26.
3. Hattersley AT, Ellard S, Shepherd M, Frayling TM, Bulman M, Ballantyne L, et al. Phe-notype - genotype relationships in maturity-onset diabetes of the young. In Matschinsky FM, Magnusson MA (eds). Molecular Pathogenesis of MODYs. Frontiers Diabetes. Basel: Karger, 2000.
4. Kim S, Ma X, Weremowicz S, Ercolino T, Powers C, Mlynarski W, et al. Identification of a locus for maturity-onset diabetes of the young on chromosome 8p23. Diabetes. 2004;3: 1375-84.
5. Fajans SS, Bell GI and Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. New Engl J Med. 2001;345:971-80.
6. Coustan DR, Nelson C, Carpenter MW. Maternal age and screening for gestational diabetes. A population-based study. Obstet Gynecol. 1989;73:557-61.
7. Wein P, Beischer N. Gestational diabetes. In twin pregnancy: prevalence and long term implications. Aust NZ J Obstet Gynaecol. 1992;32(4):325-7.
8. Nahum GG, Huffaker BJ. Racial differences in oral glucose screening tests. Establishing race-specific criteria for abnormality in pregnancy. Obstet Gynecol. 1993;81:517-22.
9. Groop L, Forsblom C, Lehtovirta M, Tuorm T, Karanko S, Nissen M, et al. Metabolic consequences of a family history of NIDDM (the Botnia study): evidence of sex-specific parental effects. Diabetes. 1996;45:1585-93.
10. Buchanon T and Xiang A. Gestational diabetes mellitus. J Clin Invest. 2005;115(3): 485-91.
11. Institute of Medicine. Nutrition during pregnancy, weight gain and nutrient supplements. Report of the Subcommittee on Nutritional Status and Weight Gain during Pregnancy, Subcommittee on Dietary Intake and Nutrient Supplements During Pregnancy, Committee on Nutritional Status During Pregnancy and Lactation, Food and Nutrition Board. Washington, DC. National Academy Press. 1990:1-233.
12. O'Sullivan JB, Mahan CM. Criteria for the glucose tolerance test in pregnancy. Diabetes. 1964;13:278-85.
13. World Health Organization. Diabetes mellitus, report of a WHO Study Group. Geneva: WHO 1985. Tech Rep. Ser. 727.
14. Ragoobirsingh D, Lewis Fuller G, Morrison. The Jamaican diabetes survey. A protocol for the Caribbean. Diabetes Care. 1995;18(9): 1277-9.
15. Sacks D, Chen W, Wolde-Tsadik G, Buchanon T. Fasting plasma glucose test at first prenatal visit as a screen for gestational diabetes. Obstetrics & Gynaecology. 2003;101:1197-203.
16. Ko G, Tam WH, Chen JC, Rogers M. Prevalence of gestational diabetes mellitus in Hong Kong based on 1998 criteria. Diabetic Medicine. 2002;19:80
17. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis Model Assessment. Insulin resistance and β cell function from glucose concentrations in man. Diabetologia. 1985;28:412-9.
18. Fulton RE, Salasek ML, DuTeau NM, Black WC. SSCP analysis of cDNA markers provides a dense linkage map of the Aedes Aegyptigenome. Genetics. 2001;158:715-26.
19. Ford E, Giles W, Mokdad A. Increasing prevalence of the metabolic syndrome amongst US adults. Diabetes Care. 2004;27:2444-9.
20. United Nations. International convention on the elimination of all forms of racial discrimination. Geneva: United Nations; 2001. CERD/ C/383/Add.l
21. Benjamin E, Winters D, Mayfield J, Gohdes D. Diabetes in pregnancy in Zuni Indian women. Prevalence and subsequent development of clinical diabetes after gestational diabetes. Diabetes Care. 2002;25:487-93.
22. Rodriques E, Robinson E, Gray-Donald S. Prevalence of gestational diabetes mellitus among James Bay Cree women in Northern Quebec. Canadian Medical Association Journal. 1999;160(2):1293-97.
23. Dyck R, Klomp H,Tan L, Turnell R, Boctor M. A comparison of rates, risk factors, and outcomes of gestational diabetes between Aboriginal and Non-Aboriginal women in the Saskatoon Health District. Diabetes Care. 2002;16(9):1231-5.
24. Dabelea D, Snell-Bergeon J, Hartsfield C, Kischoff K, Hamman R, Me Duffie R. Increasing prevalence of gestational diabetes over time and by birth cohort. Diabetes Care. 2005;28:579-84.
25. Watanabe RM, Valle T, Hauser ER, Ghosh S, Eriksson J, Kohtamaki K, et al. Familiarity of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States investigation of NIDDM genetics (FUSION) study investigators. Hum Hered. 1990;49:159-68.
26. Poulsen P, Levin K, Petersen I, Christensen K, Beck-Nielsen H, Vaag A. Heritability of insulin secretion, peripheral and hepatic insulin action, and intracellular glucose partitioning in young and old Danish twins. Diabetes. 2005;54:275-83.
27. Catalano OM, Tyzbir ED, Sims EA. Incidence and significance of islet cell antibodies in women with previous gestational diabetes. Diabetes Care. 1990;13:478-82.
28. Mauricio D, Corcoy RM, Codina M, Balsells M, Puig-Domingo M, Pou Jm, et al. Islet cell antibodies identify a subset of gestational diabetic women with higher risk of developing diabetes shortly after pregnancy. Diab Nutr Metab. 1992;5:237-41.
29. Damm P, Kuhl C, Buschard K, Jakobsen BK, Svejgaard A, Sodoyez-Goffaux F, et al. Prevalence and predictive value of women with islet cell antibodies and insulin autoantibodies in women with gestational diabetes. Diabetic Med. 1994;11:558-63.
30. Barcelo A and Rajpathak S. Incidence and prevalence of diabetes mellitus in the Americas. Rev Panam Salud Publica. 2001;10(5): 301-8.
31. Boberg J, Carlson LA, Freyschuss U, Lassers BW, Wahlqvist ML. Sphlanchic secretion rates of plasma triglycerides and total and Splanchnic turnover of plasma free fatty acids in men with normo- and hypertriglyceridaemia. Eur J Clin Invest. 1992;9:454-66.
32. Dunn FL, Grundy SM, Bilheimer DW, Havel RJ, Raskin P. Impaired catabolism of very low-density lipoprotein-triglyceride in a family with primary hypertriglyceridaemia. Metabolism. 1985;34:316-24.
33. Lalouel JM, Wilson DE, Iverius P. Lipoprotein lipase and hepatic triglyceride lipase. Molecular and genetic aspects. Curr Opin Lipidol. 1992;3:86-95.
34. Aalto-Setala K, Fisher EA, Chen X, Chajek-Shaul T, Hayek T, Zechner R, et al. Mechanism of hypertriglyceridaemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII reduced apo E on particles. J Clin Invest. 1992;9:889-900.
35. Dammerman M, Sandkuijl LA, Halaas JL, Chung W, Breslow JL. An apolipoprotein CIII haplotype protective against hypertriglyceridaemia is specified by promoter and 3' untranslated region polymorphisms. Proc Natl Acad Sci USA. 1993;90:4562-6.
36. Langer O. Management of gestational diabetes. Clin Perinatol.l993;20:l- 15.
37. Super DM, Edelberg SC, Philipson EH, Hertz RH, Kachan SC. Diagnosis of gestational diabetes in early pregnancy. Diabetes Care. 1991; 14(4):288-94.
38. Shaat N,Ekelund M, Lernmark A,Ivarsson S, Almgren P, Berntorp K, et al. Association of the E23K polymorphism in the KCNJ11 gene with gestational diabetes mellitus. Diabetologia. 2005;48(12):2544-51.
39. Zaidi FK,Wareham NJ, McCarthy MI, Hold-stock J, Kalloo-Hosein H, Krook A, et al. Homozygosity for a common polymorphism in the islet-specific promoter of the gluco-kinase gene is associated with a reduced early insulin response to oral glucose in pregnant women. Diabet Medicine. 1997;14:228-34.
40. Leipold H, Knofler M, Gruber C, Haslinger P, Bancer-Todesca D, Worda C.Calpain-10 haplotype combination and association with gestational diabetes mellitus. Obstet Gynecol. 2004;103:1235-40.
41. Rissanen J, Markkanen A, Karkkainen P, Pihlajamaki J, Kekalainen P, Mykkanen L, et al. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care. 2000;23:70-3.
42. Frayling TM, Lindgren CM, Chevre JC, Menzel S, Wishart M, Benmezroua Y, et al. A genome-wide scan in families with maturity onset diabetes of the young: evidence for further genetic heterogeneity. Diabetes. 2003; 52(3):872-81.